-Search query
-Search result
Showing 1 - 50 of 261 items for (author: king & ja)

EMDB-67283: 
C1 Symmetry of DNA tesseract
Method: single particle / : Shiu SCC

EMDB-67284: 
Octahedral Symmetry of DNA Tesseract
Method: single particle / : Shiu SCC

EMDB-45734: 
Novel designed icosahedral nanoparticle I3-A6
Method: single particle / : Haas CM, Jasti N, Dosey AM, Gillespie R, Allen JD, Leaf EM, Crispin M, DeForest C, Kanekiyo M, King NP

EMDB-45735: 
Novel designed icosahedral nanoparticle I3-A7
Method: single particle / : Haas CM, Jasti N, Dosey AM, Gillespie R, McGowan J, Allen JD, Leaf EM, Crispin M, DeForest C, Kanekiyo M, King NP

EMDB-45736: 
Novel designed icosahedral nanoparticle I3-D12
Method: single particle / : Haas CM, Jasti N, Dosey AM, Gillespie R, McGowan J, Allen JD, Leaf EM, Crispin M, DeForest C, Kanekiyo M, King NP

PDB-9clz: 
Novel designed icosahedral nanoparticle I3-A6
Method: single particle / : Haas CM, Jasti N, Dosey AM, Gillespie R, Allen JD, Leaf EM, Crispin M, DeForest C, Kanekiyo M, King NP

PDB-9cm0: 
Novel designed icosahedral nanoparticle I3-A7
Method: single particle / : Haas CM, Jasti N, Dosey AM, Gillespie R, McGowan J, Allen JD, Leaf EM, Crispin M, DeForest C, Kanekiyo M, King NP

PDB-9cm1: 
Novel designed icosahedral nanoparticle I3-D12
Method: single particle / : Haas CM, Jasti N, Dosey AM, Gillespie R, McGowan J, Allen JD, Leaf EM, Crispin M, DeForest C, Kanekiyo M, King NP

EMDB-46708: 
Molecular basis of pathogenicity of the recently emerged FCoV-23 coronavirus. Complex of fAPN with FCoV-23 RBD
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)

EMDB-46709: 
Molecular basis of pathogenicity of the recently emerged FCoV-23 coronavirus. FCoV-23 S short
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)

EMDB-46710: 
Molecular basis of pathogenicity of the recently emerged FCoV-23 coronavirus. FCoV-23 S Do in proximal conformation (local refinement)
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)

EMDB-46714: 
Molecular basis of pathogenicity of the recently emerged FCoV-23 coronavirus. FCoV-23 S long with Do in swung-out conformation
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)

EMDB-46716: 
Molecular basis of pathogenicity of the recently emerged FCoV-23 coronavirus. FCoV-23 S long domain 0 in swung-out conformation (local refinement)
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)

EMDB-46739: 
Molecular basis of pathogenicity of the recently emerged FCoV-23 coronavirus. FCoV-23 S long with Do in mixed conformations (global refinement).
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)

PDB-9daz: 
Molecular basis of pathogenicity of the recently emerged FCoV-23 coronavirus. Complex of fAPN with FCoV-23 RBD
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)

PDB-9db0: 
Molecular basis of pathogenicity of the recently emerged FCoV-23 coronavirus. FCoV-23 S short
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)

PDB-9db1: 
Molecular basis of pathogenicity of the recently emerged FCoV-23 coronavirus. FCoV-23 S Do in proximal conformation (local refinement)
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)

PDB-9db3: 
Molecular basis of pathogenicity of the recently emerged FCoV-23 coronavirus. FCoV-23 S long with Do in swung-out conformation
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)

PDB-9dbe: 
Molecular basis of pathogenicity of the recently emerged FCoV-23 coronavirus. FCoV-23 S long domain 0 in swung-out conformation (local refinement)
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)

PDB-9dbz: 
Molecular basis of pathogenicity of the recently emerged FCoV-23 coronavirus. FCoV-23 S long with Do in mixed conformations (global refinement).
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)

EMDB-48283: 
61-12A01 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48286: 
206-3G08 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48287: 
206-9C09 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48290: 
273-4D01 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48291: 
253-7A03 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-70490: 
BG505 GT1.1 SOSIP in complex with gp41-base epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70491: 
BG505 GT1.1 SOSIP in complex with V1V2V3 epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70492: 
BG505 GT1.1 SOSIP in complex with C3V5 epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70493: 
BG505 GT1.1 SOSIP in complex with CD4bs epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70494: 
BG505 GT1.1 SOSIP in complex with gp41 glycan hole epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70495: 
BG505 GT1.1 SOSIP in complex with gp41 fusion peptide epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

PDB-9mi0: 
61-12A01 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

PDB-9mia: 
206-3G08 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

PDB-9mib: 
206-9C09 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

PDB-9mih: 
273-4D01 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

PDB-9mii: 
253-7A03 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-51378: 
Structure of the human mitochondrial pyruvate carrier inhibited by a UK5099-derivative
Method: single particle / : Sichrovsky M, Lacabanne D, Ruprecht JJ, Rana JJ, Stanik K, Dionysopoulou M, Sowton AP, King MS, Jones S, Cooper L, Hardwick SW, Paris G, Chirgadze DY, Ding S, Fearnley IMF, Palmer S, Pardon E, Steyaert J, Leone V, Forrest LR, Tavoulari S, Kunji ERS

EMDB-51379: 
Structure of the human mitochondrial pyruvate carrier inhibited by zaprinast
Method: single particle / : Sichrovsky M, Lacabanne D, Ruprecht JJ, Rana JJ, Stanik K, Dionysopoulou M, Sowton AP, King MS, Jones S, Cooper L, Hardwick SW, Paris G, Chirgadze DY, Ding S, Fearnley IM, Palmer S, Pardon E, Steyaert J, Leone V, Forrest LR, Tavoulari S, Kunji ERS

EMDB-51380: 
Structure of the human mitochondrial pyruvate carrier in the apo-state
Method: single particle / : Sichrovsky M, Lacabanne D, Ruprecht JJ, Rana JJ, Stanik K, Dionysopoulou M, Sowton AP, King MS, Jones S, Cooper L, Hardwick SW, Paris G, Chirgadze DY, Ding S, Fearnley IM, Palmer S, Pardon E, Steyaert J, Leone V, Forrest LR, Tavoulari S, Kunji ERS

EMDB-51381: 
Structure of the human mitochondrial pyruvate carrier inhibited by mitoglitazone
Method: single particle / : Sichrovsky M, Lacabanne D, Ruprecht JJ, Rana JJ, Stanik K, Dionysopoulou M, King MS, Sowton AP, Jones S, Cooper L, Hardwick SW, Paris G, Chirgadze DY, Ding S, Fearnley IM, Palmer S, Pardon E, Steyaert J, Leone V, Forrest LR, Tavoulari S, Kunji ERS

PDB-9giv: 
Structure of the human mitochondrial pyruvate carrier inhibited by a UK5099-derivative
Method: single particle / : Sichrovsky M, Lacabanne D, Ruprecht JJ, Rana JJ, Stanik K, Dionysopoulou M, Sowton AP, King MS, Jones S, Cooper L, Hardwick SW, Paris G, Chirgadze DY, Ding S, Fearnley IMF, Palmer S, Pardon E, Steyaert J, Leone V, Forrest LR, Tavoulari S, Kunji ERS

PDB-9giw: 
Structure of the human mitochondrial pyruvate carrier inhibited by zaprinast
Method: single particle / : Sichrovsky M, Lacabanne D, Ruprecht JJ, Rana JJ, Stanik K, Dionysopoulou M, Sowton AP, King MS, Jones S, Cooper L, Hardwick SW, Paris G, Chirgadze DY, Ding S, Fearnley IM, Palmer S, Pardon E, Steyaert J, Leone V, Forrest LR, Tavoulari S, Kunji ERS

PDB-9gix: 
Structure of the human mitochondrial pyruvate carrier in the apo-state
Method: single particle / : Sichrovsky M, Lacabanne D, Ruprecht JJ, Rana JJ, Stanik K, Dionysopoulou M, Sowton AP, King MS, Jones S, Cooper L, Hardwick SW, Paris G, Chirgadze DY, Ding S, Fearnley IM, Palmer S, Pardon E, Steyaert J, Leone V, Forrest LR, Tavoulari S, Kunji ERS

PDB-9giy: 
Structure of the human mitochondrial pyruvate carrier inhibited by mitoglitazone
Method: single particle / : Sichrovsky M, Lacabanne D, Ruprecht JJ, Rana JJ, Stanik K, Dionysopoulou M, King MS, Sowton AP, Jones S, Cooper L, Hardwick SW, Paris G, Chirgadze DY, Ding S, Fearnley IM, Palmer S, Pardon E, Steyaert J, Leone V, Forrest LR, Tavoulari S, Kunji ERS

EMDB-50894: 
Proton conductance by human uncoupling protein 1 is inhibited by both purine and pyrimidine nucleotides
Method: single particle / : Jones SA, Sowton AP, Lacabanne D, King MS, Palmer SM, Zogg T, Pardon E, Steyaert J, Ruprecht JJ, Kunji ERS

PDB-9fzq: 
Proton conductance by human uncoupling protein 1 is inhibited by both purine and pyrimidine nucleotides
Method: single particle / : Jones SA, Sowton AP, Lacabanne D, King MS, Palmer SM, Zogg T, Pardon E, Steyaert J, Ruprecht JJ, Kunji ERS

EMDB-52458: 
In vitro grown K58N Alpha-Synuclein Fibrils
Method: single particle / : Sicking K, Al-Azzani M, Outeiro TF, Fernandez-Busnadiego R

PDB-9hxa: 
In vitro grown K58N Alpha-Synuclein Fibrils
Method: single particle / : Sicking K, Al-Azzani M, Outeiro TF, Fernandez-Busnadiego R

EMDB-52165: 
In vitro grown WT Alpha-Synuclein Fibrils
Method: single particle / : Sicking K, Al-Azzani M, Outeiro TF, Fernandez-Busnadiego R

PDB-9hgr: 
In vitro grown WT Alpha-Synuclein Fibrils
Method: single particle / : Sicking K, Al-Azzani M, Outeiro TF, Fernandez-Busnadiego R
Pages:
Movie
Controller
Structure viewers
About EMN search



wwPDB to switch to version 3 of the EMDB data model
